US Patent 7304174 CaSR antagonist
Patent 7304174 was granted and assigned to Japan Tobacco on December, 2007 by the United States Patent and Trademark Office.
All edits
Edits on 1 Sep, 2023
Golden AI
Edits made to:
Article (+147 characters)
Article
Patent abstract
A compound represented by the following formula (1), a pharmaceutically acceptable salt thereof or an optically active form thereof:
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07304174 CaSR antagonist US Patent 7304174 CaSR antagonist
Infobox
Patent Number
0730417400
Patent Number
730417400
Edits on 23 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 26 Mar, 2023
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073041740
Date of Patent
December 4, 2007
0Patent Application Number
108304800
Date Filed
April 23, 2004
0Official Website
Patent Primary Examiner
Edits on 24 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
073041740
Date of Patent
December 4, 2007
0Patent Application Number
108304800
Date Filed
April 23, 2004
0Official Website
Patent Primary Examiner
Edits on 17 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 23 Nov, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07304174 CaSR antagonist
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07304174
Date of patent
December 4, 2007
Patent application number
10830480
Date Filed
April 23, 2004
Patent primary examiner
Find more entities like US Patent 7304174 CaSR antagonist
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
